The Current Ratio as of November 2024 (TTM) for Tenaya Therapeutics, Inc. (TNYA) is 5.27

According to Tenaya Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.27. This represents a change of -9.00% compared to the average of 5.80 of the last 4 quarters.

Tenaya Therapeutics, Inc. (TNYA) Historical Current Ratio (quarterly & annually)

How has TNYA Current Ratio performed in the past?

The mean historical Current Ratio of Tenaya Therapeutics, Inc. over the last ten years is 11.43. The current 5.27 Current Ratio has changed 4.52% with respect to the historical average. Over the past ten years (40 quarters), TNYA's Current Ratio was at its highest in in the December 2020 quarter at 25.78. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Tenaya Therapeutics, Inc. (TNYA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Tenaya Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tenaya Therapeutics, Inc. (TNYA) Average Current Ratio

How has TNYA Current Ratio performed in the past?

The current Current Ratio of Tenaya Therapeutics, Inc. (TNYA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Tenaya Therapeutics, Inc. (TNYA) Current Ratio vs. Peers

How is TNYA’s Current Ratio compared to its peers?

Tenaya Therapeutics, Inc.’s Current Ratio is less than Bicycle Therapeutics plc (17.13), greater than IGM Biosciences, Inc. (5.22), less than Monte Rosa Therapeutics, Inc. (6.03), greater than Stoke Therapeutics, Inc. (5.09), greater than Biomea Fusion, Inc. (3.39), less than Akero Therapeutics, Inc. (17.25), greater than Homology Medicines, Inc. (4.19), less than Gossamer Bio, Inc. (6.74), greater than Rani Therapeutics Holdings, Inc. (1.60), greater than Vincerx Pharma, Inc. (2.17), greater than Corvus Pharmaceuticals, Inc. (0.92), greater than ALX Oncology Holdings Inc. (4.82), greater than Eyenovia, Inc. (0.74), less than Alpha Tau Medical Ltd. (10.99), less than Ocular Therapeutix, Inc. (13.01), less than Inozyme Pharma, Inc. (7.68),

Build a custom stock screener for Tenaya Therapeutics, Inc. (TNYA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tenaya Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tenaya Therapeutics, Inc. (TNYA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tenaya Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.